We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.00 | 0.10% | 976.00 | 981.00 | 983.00 | 991.00 | 970.00 | 970.00 | 184,523 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5843 | 16.79 | 703.5M |
TIDMCVSG
RNS Number : 2151J
CVS Group plc
03 December 2018
03 December 2018
CVS Group plc
Grant of Options under CVS Group plc SAYE Option Scheme and
Total Voting Rights
CVS Group plc (the "Company") announces that as part of its all employee Save As You Earn share scheme (the "SAYE Scheme"), Richard Fairman, finance director, elected to participate in the SAYE scheme and was granted 737 SAYE Scheme options.
Eligible employees were invited to subscribe for options over ordinary shares of 0.2 pence each ("Ordinary Shares") with an option price of 830 pence per share, representing a 10% discount to the share price which was calculated using the closing share price prior to the 5th November 2018, being the invite date.
Pursuant to this, a total of 425,974 SAYE Scheme options over Ordinary Shares were granted on 29 November 2018, equating to 0.6% of the current issued ordinary share capital.
The attached notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the number of options granted on 29 May 2018 under the SAYE Scheme.
In conformity with the Disclosure Guidance and Transparency Rule 5.6.1, the Company notifies the market of the following: The Company's total issued share capital is 70,519,031 ordinary shares of 0.2 pence each with one voting right per share. The Company does not hold any ordinary shares in Treasury. This figure of 70,519,031 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Richard Fairman ----------------------------- ------------------------------------ 2 Reason for the notification ------------------------------------------------------------------- a) Position/status Finance Director ----------------------------- ------------------------------------ b) Initial notification Initial Notification /Amendment ----------------------------- ------------------------------------ 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------- a) Name CVS Group plc ----------------------------- ------------------------------------ b) LEI 213800J41XDQ2NX48O05 ----------------------------- ------------------------------------ 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------- a) Description of the Ordinary shares of 0.2 pence each financial instrument, type of instrument GB00B2863827 Identification code ----------------------------- ------------------------------------ b) Nature of the transaction Grant of Options under the SAYE. ----------------------------- ------------------------------------ c) Price(s) and volume(s) Price(s) Volume(s) Option price of 830p 737 ---------- ----------------------------- ------------------------------------ d) Aggregated information - Aggregated volume - Price ----------------------------- ------------------------------------ e) Date of the transaction 29 November 2018 ----------------------------- ------------------------------------ f) Place of the transaction Off market ----------------------------- ------------------------------------ Contacts: Tel: 01379 644 CVS Group plc 288 Simon Innes, Chief Executive Richard Fairman, Finance Director N+1 Singer (Nominated Adviser & Broker) Tel: 020 7496 Aubrey Powell, Jen Boorer 3000 Rachel Hayes
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCFKNDBKBDDFBK
(END) Dow Jones Newswires
December 03, 2018 05:30 ET (10:30 GMT)
1 Year Cvs Chart |
1 Month Cvs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions